SCHEMBL20734808

SCHEMBL20734808

Cc1ccc(COC2=CC(=O)NC2Cc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
HTT P42858 2/20 0.41
NPC1 O15118 2/20 0.41
ALOX15 P16050 1/20 0.40
PLA2G10 O15496 1/20 0.39
PLA2G5 P39877 1/20 0.39
LMNA P02545 2/20 0.39
HRH3 Q9Y5N1 1/20 0.39
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
GRM5 P41594 1/20 0.37
CES2 O00748 2/20 0.36
AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20734807 1.00 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4CHTT
SCHEMBL20734910 0.87 MMP1 (0.48) MEN1KMT2AKDM4CHTTNPC1
SCHEMBL24332981 0.87 LMNA (0.40) ALDH1A1MEN1KMT2AHTTNPC1
SCHEMBL20734933 0.87 NPSR1 (0.40) MEN1KMT2AKDM4CHTTPLA2G10
SCHEMBL20735047 0.87 NPSR1 (0.40) MEN1KMT2AKDM4CHTTPLA2G10
SCHEMBL21927104 0.85 MEN1 (0.38) MEN1KMT2AKDM4CHTTPLA2G10
SCHEMBL24333202 0.84 ALDH1A1 (0.39) ALDH1A1MEN1KMT2AKDM4CHTT
SCHEMBL20734853 0.84 MAOB (0.50) MEN1KMT2AKDM4CHTTNPC1
SCHEMBL20734851 0.84 MAOB (0.50) MEN1KMT2AKDM4CHTTNPC1
SCHEMBL20734891 0.83 PLA2G10 (0.39) ALDH1A1MEN1KMT2APLA2G10PLA2G5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130733-B2 4-OXO-alkylated tetramic acid compound, preparation method and use thereof BEIJING JOEKAI BIOTECH. LLC (CN) 2021-09-28 US disclosed
US-20200361868-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PREPARATION METHOD AND USE THEREOF BEIJING JOEKAI BIOTECH. LLC (CN) 2020-11-19 US disclosed
WO-2019029274-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND AND PREPARATION METHOD THEREFOR 北京卓凯生物技术有限公司 2019-02-14 WO disclosed
WO-2019029273-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京卓凯生物技术有限公司 2019-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130733-B2 4-OXO-alkylated tetramic acid compound, preparation method and use thereof HTT, PARK7, PSEN1 ALDH1A1 1056/4885MEN1 2261/4885KMT2A 921/4885
US-20200361868-A1 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PREPARATION METHOD AND USE THEREOF HTT, PARK7, PSEN1 ALDH1A1 1056/4885MEN1 2261/4885KMT2A 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.